Quantum Cyber N.V. (QUCY) AI Stock Analysis

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company seeks acquisitions and partnerships in fields such as post-quantum cryptography, zero-trust architecture, and national security technologies. In addition, it develops platforms integrating artificial intelligence and quantum computing technologies for autonomous control systems deployed in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Formerly known as Mainz Biomed N.V., the business changed its name to Quantum Cyber N.V. in April 2026 and is headquartered in Mainz, Germany, with 10 employees.

Revenue decreased from $893,991 in FY2024 to $537,080 in FY2025, representing a revenue decline of 39.9%. Over the four-year period from FY2021 to FY2025, revenue registered a compound annual growth rate of -1.8%. Despite contracting revenue, gross margin expanded from 30.8% in FY2021 and 64.3% in FY2024 to 72.6% in FY2025. The company posted an operating margin of -2414.0% and a net income of -$16.2M in FY2025, following a net loss of -$21.7M in FY2024. For the trailing twelve months ended June 30, 2026, revenue was $537,080 with quarterly revenue growth falling 32.9% year-over-year and an operating margin of -3205.6%.

As of June 30, 2026, Quantum Cyber held $13.4M in cash and short-term investments and $168,670 in total debt, yielding net cash of $13.2M. Total assets stood at $23.4M against shareholders' equity of $20.4M. Liquidity indicators show a current ratio of 5.56 and a debt-to-equity ratio of 0.01. Operating cash flow for FY2025 was -$11.0M, leading to free cash flow of -$12.0M after accounting for capital expenditures of $1.1M.

At a last close of $1.06 on October 16, 2026, Quantum Cyber had a market cap of $92.5M and an enterprise value of $97.8M. The stock traded at a price-to-sales multiple of 172.1x and an enterprise value-to-revenue multiple of 182.1x, well above the 4.1x price-to-sales median of its US-listed Healthcare peers. Its price-to-book ratio stood at 5.5x. Over the trailing 12 months, the stock produced a return of -24.8%, lagging the S&P 500 return of 16.8%.

Wall Street coverage consists of 2 analysts, with 1 StrongBuy and 1 Hold rating. The mean price target is $9.00, which represents an upside of 749.1% versus the last close of $1.06. For the current fiscal year ending December 31, 2026, consensus estimates project an EPS of -$0.49 and revenue of $2.0M. For the next fiscal year, analysts estimate revenue of $4.6M and an EPS of -$0.90. Quantum Cyber beat EPS estimates in 3 of the last 4 quarters, and its next earnings date is November 13, 2026.

This page is an AI-written research summary of Quantum Cyber N.V. (QUCY). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: QUCY income statement, QUCY balance sheet, QUCY key metrics, QUCY analyst forecast, QUCY chart. See the QUCY stock overview for the latest quote and news.